Validity of Sentinel Lymphnode Biopsy After Neoadjuvant Chemotherapy in Breast Cancer Patients With Radiologically Positive Axillary Lymph Nodes
N/A
20 Years
70 Years
20 Years
70 Years
Not Enrolling
Female
Breast Cancer
Female
Breast Cancer
Trial Information
Validity of Sentinel Lymphnode Biopsy After Neoadjuvant Chemotherapy in Breast Cancer Patients With Radiologically Positive Axillary Lymph Nodes
Inclusion Criteria:
- Advanced breast cancer patients with node-positive proved in preoperative imaging
study
- ECOG status 0-1
Exclusion Criteria:
- No previous cancer history
- No previous chemotherapy history
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Authority:
Korea: Institutional Review Board
Study ID:
GNSBCC001
NCT ID:
NCT01622478
Start Date:
December 2006
Completion Date:
November 2009
Related Keywords:
- Breast Cancer
- sentinel lymph node biopsy
- neoadjuvant chemotherapy
- breast cancer
- locally advanced breast cancer
- positive axillary lymph node
- negative conversion
- Breast Neoplasms
Name | Location |
|---|
